MangoceuticalsMGRX
13F holders, Q1 2026 (March 31)18holders
3new positions
4sold out
$0.36avg. 13F price*
At the end of Q1 2026, 18 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings, unchanged from Q4 2025. 3 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($70K), Ikarian Capital, LLC ($50K) and Vanguard Capital Management LLC ($44K).
- Company
- Mangoceuticals Inc.
- CUSIP
- 56270V205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $15K |
| Exits | 4 | $1.2M |
All 13F filers, Q4 2025 → Q1 2026: 181,272 shares bought and 1,582,492 shares sold, net −1,401,220 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Geode Capital Management, LLC | 0.00% | Add +79.5% | 194,482 | $70K |
| Ikarian Capital, LLC | 0.01% | No change | 138,146 | $50K |
| Vanguard Capital Management LLC | 0.00% | — | 123,041 | $44K |
| Jane Street Group, LLC | 0.00% | Add +53.1% | 72,746 | $26K |
| Virtu Financial LLC | 0.00% | Add +82.4% | 61,028 | $22K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 57,163 | $21K |
| Boothbay Fund Management, LLC | 0.00% | No change | 38,441 | $14K |
| Northern Trust Corp. | 0.00% | No change | 37,579 | $14K |
| Ackerman Capital Advisors, LLC | 0.00% | No change | 34,500 | $12K |
| StoneX Group Inc. | 0.00% | New | 16,039 | $6K |
| XTX Topco Ltd | 0.00% | New | 13,142 | $5K |
| Sunbelt Securities, Inc. | 0.00% | No change | 12,000 | $4K |
| Goldman Sachs Group Inc. | 0.00% | New | 11,757 | $4K |
| Csenge Advisory Group | 0.00% | No change | 10,000 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +13.9% | 3,285 | $1K |
| Fortitude Family Office, LLC | 0.00% | Add +255.3% | 1,343 | $484 |
| Morgan Stanley | 0.00% | No change | 1,000 | $360 |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -21.7% | 785 | $283 |
"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.